{
  "url": "https://www.moneycontrol.com/news/business/markets/mangalam-drugs-shares-rise-88-in-13-day-run-on-back-to-back-upper-circuits-13774200.html",
  "scraped_at": "2026-01-19T15:07:11.215505",
  "title": "Mangalam Drugs shares rise 88% in 13-day run on back-to-back upper circuits",
  "published_date": "January 15, 2026/ 16:21 IST",
  "author": "Moneycontrol News",
  "content": "Mangalam Drugs and Organicsshares have surged over 88 percent in the past 13 trading sessions, hitting back-to-back upper circuits during the period.\n\nOn Wednesday, the stock hit its 5 percent upper circuit and closed at Rs 44.77 apiece on the NSE. It opened at the same level and remained locked in the upper circuit through the session.\n\nThe stock has gained 88.27 percent over the last 13 sessions.Â The stock also saw a series of bulk deals last week.\n\nOn January 7, Kedia Securities Private Limited sold around 1.38 lakh shares valued at Rs 48.35 lakh in a bulk transaction, according to exchange data.\n\nOther sellers included Neo Apex Venture LLP, which sold shares worth Rs 27.6 lakh, Epitome Trading and Investments, which sold shares worth Rs 42 lakh, and Multiplier Share and Stock Advisors Private Limited, which sold shares worth Rs 44 lakh.\n\nEarlier, in December,Kedia Securities had purchased shares worth over Rs 33 lakh in the company.\n\nData on the NSE showed that on December 29, Kedia Securities bought around 1.38 lakh shares at Rs 24.15 per share in a bulk deal, taking the transaction value to Rs 33.28 lakh.\n\nMangalam Drugs shares hit 5% upper circuit after Vijay Kedia buys stake\n\nMangalam Drugs and Organics is engaged in the manufacture of active pharmaceutical ingredients (APIs) and intermediates.\n\nDespite the recent rally, the stock is still down nearly 57 percent over the past one year, according to BSE Analytics data.\n\nDisclaimer:The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",
  "content_length": 1708,
  "tags": [],
  "category": "business"
}